Çoban, Ayşegül Demirci

Profile Picture
Profile URL
https://hdl.handle.net/20.500.14411/6921
Name Variants
Çoban, Ayşegül Demirci
Ç.,Ayşegül Demirci
Çoban,A.D.
Aysegul Demirci, Coban
C.,Aysegul Demirci
Ç., Ayşegül Demirci
C., Aysegul Demirci
A.,Çoban
Coban,A.D.
A., Coban
A. D. Çoban
Coban, Aysegul Demirci
Ayşegül Demirci, Çoban
A. D. Coban
A.D.Coban
A.D.Çoban
Job Title
Doktor Öğretim Üyesi
Email Address
aysegul.demircicoban@atilim.edu.tr
Main Affiliation
Department of Therapy and Rehabilitation
Status
Website
ORCID ID
Scopus Author ID
Turkish CoHE Profile ID
Google Scholar ID
WoS Researcher ID
JZP-9377-2024

Sustainable Development Goals

SDG data is not available
This researcher does not have a Scopus ID.
Documents

2

Citations

4

Go to WoS profile
Scholarly Output

2

Articles

2

Views / Downloads

7/0

Supervised MSc Theses

0

Supervised PhD Theses

0

WoS Citation Count

4

Scopus Citation Count

3

WoS h-index

1

Scopus h-index

1

Patents

0

Projects

0

WoS Citations per Publication

2.00

Scopus Citations per Publication

1.50

Open Access Source

1

Supervised Theses

0

Google Analytics Visitor Traffic

JournalCount
Turkish Journal of Physical Medicine and Rehabilitation1
Current Page: 1 / 1

Scopus Quartile Distribution

Competency Cloud

GCRIS Competency Cloud

Filters

20242
Reset filters

Settings

Scholarly Output Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Article
    The Effect of Combined Hydrolyzed Type 2 Collagen, Methylsulfonylmethane, Glucosamine Sulfate and Chondroitin Sulfate Supplementation on Knee Osteoarthritis Symptoms
    (Baycinar Medical Publ-baycinar Tibbi Yayincilik, 2024) Ayhan, Fikriye Figen; Coban, Aysegul Demirci; Karasu, Ayca Utkan; Karaoglan, Belgin; Cinar, Ece; Eyigor, Sibel; Dalyan, Meltem
    Objectives: This study aimed to evaluate the effects of the combined hydrolyzed type 2 collagen, methylsulfonylmethane (MSM), glucosamine sulfate (GS), and chondroitin sulfate (CS) supplement on knee pain intensity in patients with knee osteoarthritis (OA).Patients and methods: This multicenter, observational, noninterventional study included 98 patients (78 females, 20 males; mean age: 52.8 +/- 6.5 years; range, 40 to 64 years) who had Grade 1-3 knee OA between May 2022 and November 2022. The patients were prescribed the combination of hydrolyzed type 2 collagen, MSM, GS, and CS as a supplement for knee OA. The sachet form of the combined supplement containing 1250 mg hydrolyzed type 2 collagen, 750 mg MSM, 750 mg GS, and 400 mg CS was used once daily for two consecutive months. Patients were evaluated according to the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Visual Analog Scale (VAS)-pain, and Health Assessment Questionnaire (HAQ). Patients were scheduled to visit for follow-up four weeks (Visit 2) and eight weeks (Visit 3) after Visit 1 (baseline; day 0 of the study).Results: For the VAS-pain, WOMAC, WOMAC-subscale, and HAQ scores, the differences in improvement between the three visits were significant (p<0.001 for all). The patient compliance with the supplement was a median of 96.77%, both for Visit 2 and Visit 3. Conclusion: The combination of hydrolyzed type 2 collagen, MSM, GS, and CS for eight weeks in knee OA was considered an effective and safe nutritional supplement.
  • Thumbnail Image
    Article
    Citation - WoS: 4
    Citation - Scopus: 3
    The Effect of Combined Hydrolyzed Type 2 Collagen, Methylsulfonylmethane, Glucosamine Sulfate and Chondroitin Sulfate Supplementation on Knee Osteoarthritis Symptoms
    (Baycinar Medical Publ-baycinar Tibbi Yayincilik, 2024) Ayhan, Fikriye Figen; Çoban, Ayşegül Demirci; Karasu, Ayça Utkan; Karaoğlan, Belgin; Çınar, Ece; Eyigör, Sibel; Dalyan, Meltem
    Objectives: This study aimed to evaluate the effects of the combined hydrolyzed type 2 collagen, methylsulfonylmethane (MSM), glucosamine sulfate (GS), and chondroitin sulfate (CS) supplement on knee pain intensity in patients with knee osteoarthritis (OA). Patients and methods: This multicenter, observational, noninterventional study included 98 patients (78 females, 20 males; mean age: 52.8±6.5 years; range, 40 to 64 years) who had Grade 1-3 knee OA between May 2022 and November 2022. The patients were prescribed the combination of hydrolyzed type 2 collagen, MSM, GS, and CS as a supplement for knee OA. The sachet form of the combined supplement containing 1250 mg hydrolyzed type 2 collagen, 750 mg MSM, 750 mg GS, and 400 mg CS was used once daily for two consecutive months. Patients were evaluated according to the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Visual Analog Scale (VAS)-pain, and Health Assessment Questionnaire (HAQ). Patients were scheduled to visit for follow-up four weeks (Visit 2) and eight weeks (Visit 3) after Visit 1 (baseline; day 0 of the study). Results: For the VAS-pain, WOMAC, WOMAC-subscale, and HAQ scores, the differences in improvement between the three visits were significant (p<0.001 for all). The patient compliance with the supplement was a median of 96.77%, both for Visit 2 and Visit 3. Conclusion: The combination of hydrolyzed type 2 collagen, MSM, GS, and CS for eight weeks in knee OA was considered an effective and safe nutritional supplement.